Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-11-315841
Filing Date
2011-11-17
Accepted
2011-11-17 17:18:07
Documents
6
Effectiveness Date
2011-11-17

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d251610ds8.htm S-8 52706
2 ARTICLES OF ASSOCIATION OF THE REGISTRANT d251610dex41.htm EX-4.1 178056
3 OPINION OF DE BRAUW BLACKSTONE WESTBROEK N.V. d251610dex5.htm EX-5 30746
4 CONSENT OF ERNST & YOUNG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT d251610dex232.htm EX-23.2 1716
5 AMENDED AND RESTATED 2005 STOCK PLAN d251610dex991.htm EX-99.1 106299
6 GRAPHIC g251610g58e50.gif GRAPHIC 531
  Complete submission text file 0001193125-11-315841.txt   371362
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-178035 | Film No.: 111213996
SIC: 2836 Biological Products, (No Diagnostic Substances)